We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Beckman Coulter and SphingoTec Partner to Improve Kidney Health Assessment in Critical Care

By LabMedica International staff writers
Posted on 10 Oct 2024
Print article
Image: This alliance aims to significantly enhance the diagnostic capabilities for AKI (Photo courtesy of 123RF)
Image: This alliance aims to significantly enhance the diagnostic capabilities for AKI (Photo courtesy of 123RF)

The incidence of acute kidney injury (AKI) is rising in both hospital and community settings, with an estimated 13 million people affected globally each year. Current biomarkers used in critical care to detect AKI include serum creatinine and urine output. However, these biomarkers have significant limitations, offering delayed, error-prone, and unspecific insights. Emerging research highlights that the kidney function biomarker Proenkephalin 119-159 (penKid) can address these shortcomings. PenKid, a real-time biomarker present in plasma, provides a more accurate and timely assessment of kidney function, especially in critical care environments. Unlike traditional methods, penKid has been shown to detect kidney function decline earlier and is not influenced by inflammation, which may allow for earlier interventions and better patient outcomes. Now, a new partnership aims to improve kidney health assessment in critical care by leveraging the penKid kidney function biomarker.

In an effort to enhance kidney health assessments in critical care, Beckman Coulter Diagnostics (Brea, CA, USA) has partnered with SphingoTec GmbH (Hennigsdorf, Germany) to integrate SphingoTec's penKid assay into Beckman Coulter's extensive test offerings on its Access Family of immunoassay analyzers. This collaboration marks the first central laboratory license for a penKid assay and seeks to significantly expand diagnostic capabilities for AKI worldwide by leveraging Beckman Coulter's large installed base of instruments. Under this agreement, Beckman Coulter will develop and validate a fully automated diagnostic test for penKid using SphingoTec's IVD-certified assay, which has already been implemented as a routine test in select university hospitals. This partnership will make penKid assays widely available in central laboratories, enabling critical care physicians to perform timely and accurate kidney health assessments.

“Acute kidney injury exerts a profound impact on patients globally, complicates acute and chronic illnesses frequently resulting in poor outcomes, and rivals many other critical diseases in its severity and consequences,” said Kevin O’Reilly, President, at Beckman Coulter Diagnostics. “The published evidence for penKid testing combined with SphingoTec’s scientific expertise provides an exciting opportunity to improve kidney health management. Working with SphingoTec, our goal is to expand access to and improve workflow from this important kidney health innovation underscoring our commitment to enhancing patient care worldwide.”

“The development of a penKid-based assay for use on Beckman Coulter’s globally installed immunoassay platforms represents a significant step toward realizing our vision of transforming diagnostic innovation into tangible patient benefits,” added Deborah Bergmann, Managing Director and CEO of SphingoTec. “This partnership accelerates our mission to deliver precise, actionable insights to clinicians worldwide, ultimately improving outcomes for patients suffering from acute kidney injury.”

Related Links:
Beckman Coulter Diagnostics
SphingoTec GmbH 

Gold Member
Troponin T QC
Troponin T Quality Control
Unit-Dose Packaging solution
HLX
New
Leishmania Test
Leishmania Real Time PCR Kit
New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: Heart attacks could be ruled out early with a new test, according to researchers (Photo courtesy of Mindray)

New High-Sensitivity Cardiac Troponin Test Quickly Rules Out Heart Attack

Patients arriving at an emergency department with symptoms like chest or arm pain, indicative of a potential heart attack, often prefer the comfort of home over a hospital bed—especially if they can be... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Immunology

view channel
Image: An immune response is initiated when an antigen-presenting cell (pink) presents foreign material to a T-cell (blue) (Photo courtesy of JAX)

Advanced Imaging Method Maps Immune Cell Connections to Predict Cancer Patients Survival

A growing tumor is influenced not only by the tumor cells themselves but also by the surrounding tissue, which alters its biology. Immune cells communicate by transferring vital signaling proteins to their... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image: LMU’s Professor Frederick Klauschen developed the novel approach that can improve diagnostic accuracy (Photo courtesy of LMU Munich)

AI Tool Uses Imaging Data to Detect Less Frequent GI Diseases

Artificial intelligence (AI) is already being utilized in various medical fields, demonstrating significant potential in aiding doctors in diagnosing diseases through imaging data. However, training AI... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.